Novo Nordisk Pharma (Pvt.) Ltd
| Market Share | 1.56% |
| Growth | -1.31% |
| Total generics | 12 |
| Headquarter | Ninakabbo, Level-9, 227/A, Gulshan Tejgaon Link Road, Tejgaon, Dhaka 1208 |
| Contact details | +880 2 989 3701 |
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 37,200 employees in 76 countries, and markets its products in more than 180 countries.
Novo nordisk set up a high-tech insulin manufacturing plant in Tongi. The plant, the third set up by the company in Asia after China and India and it is a tie-up between the Novo Nordisk and Eskayef Bangladesh Ltd, a leading local pharmaceutical company. The Nordisk-Eskayef plant will manufacture over 5 million vials a year, maintaining the high-quality standards followed by Novo Nordisk across the world. Novo Nordisk enjoys more than 80 percent share in the insulin segment of diabetic care market in Bangladesh.
Novo nordisk set up a high-tech insulin manufacturing plant in Tongi. The plant, the third set up by the company in Asia after China and India and it is a tie-up between the Novo Nordisk and Eskayef Bangladesh Ltd, a leading local pharmaceutical company. The Nordisk-Eskayef plant will manufacture over 5 million vials a year, maintaining the high-quality standards followed by Novo Nordisk across the world. Novo Nordisk enjoys more than 80 percent share in the insulin segment of diabetic care market in Bangladesh.
